Dyax
Dyax discovers, develops and commercializes treatments for hereditary angioedema and other rare diseases.
Business Model:
Revenue: $97.5M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Dyax Information
Geographic Data
Address: 55 Network Dr
City: Burlington
State: MA
Zip: 01803
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$60M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Dyax discovers, develops and commercializes treatments for hereditary angioedema and other rare diseases.
Contact Phone:
+16172252500
Contact Email:
Dyax went public on 8/25/2000 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/25/2000
IPO Valuation:
$271M
Ticker Symbol:
DYAX
IPO Price:
$15/share
Amount Raised:
$216M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
